Primary ovarian insufficiency associated with imatinib therapy.
Christopoulos
Constantinos
C
Dimakopoulou
Vasiliki
V
Rotas
Evangelos
E
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D000068877:Imatinib Mesylate; D007247:Infertility, Female / Q000139:chemically induced; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D005640:Follicle Stimulating Hormone; D011505:Protein-Tyrosine Kinases